We are live on ! Find out more
3C

361 Capital Portfolio holdings

AUM $213M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
10 Year Est. Return
AUM
$441M
AUM Growth
+$37.3M
Cap. Flow
+$11.9M
Cap. Flow %
2.71%
Top 10 Hldgs %
6.45%
Holding
442
New
174
Increased
68
Reduced
68
Closed
132

Top Buys

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$2.81M
2
GGG icon
Graco
GGG
+$2.76M
3
RVTY icon
Revvity
RVTY
+$2.71M
4
EWBC icon
East-West Bancorp
EWBC
+$2.64M
5
LW icon
Lamb Weston
LW
+$2.64M

Top Sells

Rank Stock Value
1
RL icon
Ralph Lauren
RL
+$3.13M
2
TSN icon
Tyson Foods
TSN
+$2.98M
3
TOL icon
Toll Brothers
TOL
+$2.97M
4
CAG icon
Conagra Brands
CAG
+$2.96M
5
CIT
CIT Group Inc.
CIT
+$2.95M

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.6%
3 Healthcare 12.87%
4 Consumer Discretionary 12.62%
5 Industrials 12.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJI
51
DELISTED
South Jersey Industries, Inc.
SJI
$1.9M 0.43%
56,864
+1,878
+3% +$58.9K
ALL icon
52
Allstate
ALL
$67.1B
$1.9M 0.43%
+20,809
New +$1.98M
LLY icon
53
Eli Lilly
LLY
$1.07T
$1.89M 0.43%
22,167
-1,798
-8% -$148K
VRSN icon
54
VeriSign
VRSN
$25.2B
$1.86M 0.42%
13,565
-664
-5% -$85.1K
MEDP icon
55
Medpace
MEDP
$16.5B
$1.86M 0.42%
43,173
+1,403
+3% +$56.7K
CHE icon
56
Chemed
CHE
$6.8B
$1.85M 0.42%
5,749
+189
+3% +$59.1K
INGN icon
57
Inogen
INGN
$174M
$1.85M 0.42%
9,927
-2,302
-19% -$383K
LGND icon
58
Ligand Pharmaceuticals
LGND
$5.94B
$1.85M 0.42%
14,315
-2,936
-17% -$328K
EGP icon
59
EastGroup Properties
EGP
$11.3B
$1.84M 0.42%
19,289
+634
+3% +$57.1K
AZTA icon
60
Azenta
AZTA
$1.26B
$1.84M 0.42%
+56,455
New +$1.68M
MBUU icon
61
Malibu Boats
MBUU
$554M
$1.84M 0.42%
43,818
+1,445
+3% +$57.6K
VG
62
DELISTED
Vonage Holdings Corporation
VG
$1.83M 0.42%
142,096
+4,678
+3% +$53.6K
CTRE icon
63
CareTrust REIT
CTRE
$10.1B
$1.83M 0.41%
109,468
+3,586
+3% +$53.9K
DIOD icon
64
Diodes
DIOD
$3.86B
$1.82M 0.41%
52,926
+2,684
+5% +$88.3K
TTEK icon
65
Tetra Tech
TTEK
$8.34B
$1.82M 0.41%
+155,390
New +$1.66M
CACI icon
66
CACI
CACI
$11B
$1.81M 0.41%
10,740
+352
+3% +$56.8K
PCAR icon
67
PACCAR
PCAR
$69.5B
$1.81M 0.41%
43,788
-16,935
-28% -$732K
GDOT icon
68
Green Dot
GDOT
$749M
$1.79M 0.41%
+24,383
New +$1.68M
PGTI
69
DELISTED
PGT, Inc.
PGTI
$1.79M 0.41%
+85,812
New +$1.68M
RGNX icon
70
Regenxbio
RGNX
$629M
$1.79M 0.41%
+24,915
New +$1.19M
KMG
71
DELISTED
KMG Chemicals Inc
KMG
$1.79M 0.41%
+24,234
New +$1.63M
CDNS icon
72
Cadence Design Systems
CDNS
$94B
$1.78M 0.4%
+41,185
New +$1.69M
BRKL
73
DELISTED
Brookline Bancorp
BRKL
$1.78M 0.4%
95,846
+3,148
+3% +$55.3K
RHP icon
74
Ryman Hospitality Properties
RHP
$8.52B
$1.78M 0.4%
21,445
+711
+3% +$57.5K
SRI icon
75
Stoneridge
SRI
$210M
$1.78M 0.4%
50,659
-12,867
-20% -$391K

Similar funds

361 Capital's Q2 2018 Portfolio in Review

As of Q2 2018, 361 Capital held 442 positions worth $441M, up 9.2% from $404M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

361 Capital's Q2 2018 filing shows 174 new, 68 increased, 68 reduced and 132 closed positions. Its largest new stake was Wellcare Health Plans, Inc.: 12,904 shares worth $3.18M. The largest sale was Ralph Lauren, an estimated $3.13M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • 361 Capital's largest Q2 2018 buy was Wellcare Health Plans, Inc.: 12,904 shares worth $3.18M.
  • 361 Capital added most to Old Dominion Freight Line in Q2 2018, an estimated $1.79M increase.
  • 361 Capital's biggest Q2 2018 reduction was Ralph Lauren, cutting an estimated $3.13M.
  • 361 Capital fully exited Tyson Foods in Q2 2018, selling an estimated $2.98M.
  • 361 Capital's ten largest holdings make up 6.5% of its $441M portfolio in Q2 2018.
  • 361 Capital opened 174 new positions and closed 132 in Q2 2018.
  • 361 Capital's portfolio value rose 9.2% quarter-over-quarter to $441M.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.